Cerecor OverviewTrack Cerecor's EBIT ($-85M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Cerecor (CERC) currently reports a EBIT of $-85M as of June 2026. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Cerecor's EBIT history and peer comparisons.
Cerecor's EBIT of $-85M is lower than the Healthcare sector average of $22B. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Cerecor reported $-85M in EBIT as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-85M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Cerecor, and consider following CERC for alerts when major investors trade the stock.
Cerecor is classified in the Healthcare sector. On EBIT, it currently shows $-85M versus a sector average near $22B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CERC with unrelated industries.
